Presa M, Soria A, Oyagüez I, Espinosa E, Echave M, Berrocal A, Manzano JL, Suarez J, Polanco C Nivolumab-adjuvant therapy for resected stage III-IV melanoma: a cost-effectiveness analysis for Spain 22nd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019 POSTER
